The study did not compare BAT specificity and sensitivity to SPT, sIgE or OFC specificity and sensitivity of allergy diagnosis.BAT parameters (%CD63+, %CD203c+) did not show differences between groups with different clinical symptoms(BAT results compared to medical history) (p < 0.001). This evidence concerns the gene CD63 and allergic disease.